Identification ofNeisseria meningitidisNonlipopolysaccharide Ligands for Class A Macrophage Scavenger Receptor by Using a Novel Assay
Authors:
- 1 September 2006
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 74 (9) , 5191-5199
Abstract
Macrophages (Mφ) may play an important role in the pathogenesis of invasive meningococcal infection. Previously, we have shown that the class A Mφ scavenger receptor (SR-A) is a major nonopsonic receptor forNeisseria meningitidison Mφ. SR-A contributes to host defense by binding proinflammatory polyanionic ligands such as lipopolysaccharide (LPS) and by the uptake and killing of live organisms. SR-A-deficient mouse Mφ display a substantial reduction in the number of meningococci ingested compared to wild-type Mφ, and SR-A is required for meningococcal phagocytosis but not for the release of tumor necrosis factor alpha. Although soluble lipid A and lipidIVA are reported as ligands for SR-A, we demonstrated that LPS and LPS expression were not essential for the uptake of whole meningococci. In the present study, we set out to discover protein ligand(s) for SR-A inN. meningitidislysates and outer membrane vesicles. Using various microbial mutant strains, we determined that molecules comprising the membrane capsule and pili, as well as the abundant surface Opa proteins were not essential for SR-A recognition. We developed a binding assay to detect SR-A ligands and identified three candidate proteins expressed on intact organisms, namely, NMB1220, NMB0278, and NMB0667. Soluble forms of these ligands were shown to block the binding of meningococci to CHO cells stably transfected with SR-A. Furthermore, NMB1220 was endocytosed by SR-A on Mφ and prevented internalization of soluble acetylated low-density lipoprotein. Thus, we have identified novel, unmodified protein ligands for SR-A that are able to inhibit meningococcal interactions with macrophages in vitro.Keywords
This publication has 31 references indexed in Scilit:
- Meningococcal VaccinesPediatric Drugs, 2004
- Functional Opsonic Activity of Human Serum Antibodies to Inner Core Lipopolysaccharide (galE) of Serogroup B Meningococci Measured by Flow CytometryInfection and Immunity, 2001
- The function of scavenger receptorsexpressed by macrophages and their rolein the regulation of inflammationMicrobes and Infection, 2001
- Macrophage Class A Scavenger Receptor-Mediated Phagocytosis ofEscherichia coli: Role of Cell Heterogeneity, Microbial Strain, and Culture Conditions In VitroInfection and Immunity, 2000
- Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58Science, 2000
- Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome SequencingScience, 2000
- Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes.Journal of Experimental Medicine, 1996
- Experimental infection of human nasal mucosal explants with Neisseria meningitidisJournal of Medical Microbiology, 1995
- STRUCTURES AND FUNCTIONS OF MULTILIGAND LIPOPROTEIN RECEPTORS: Macrophage Scavenger Receptors and LDL Receptor-Related Protein (LRP)Annual Review of Biochemistry, 1994
- The role of pili in the interactions of pathogenic Neisseria with cultured human endothelial cellsMolecular Microbiology, 1991